Design of CGMP Production of18F- and68Ga-Radiopharmaceuticals

Corrigendum to “Design of CGMP Production of 18F- and 68Ga-Radiopharmaceuticals”

[This corrects the article DOI: 10.1155/2014/680195.].

Radiopharmaceuticals: Production and Availability

1. The use of specific radiotracers called radiopharmaceuticals for imaging organ function and disease states is a unique capability of nuclear medicine. Unlike other imaging modalities such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI) and Ultrasonography (US), nuclear medicine procedures are capable of mapping physiological function and metabolic activity and thereby giving mo...

Radionuclide production for therapeutic radiopharmaceuticals.

A fundamental task within the framework of a project searching for new radiopharmaceuticals for systemic therapy was the evaluation of the capabilities of the Portuguese Research Reactor (RPI) for the production of several important radionuclides. The feasibility of producing 64Cu, 77As, 153Sm, 165Dy, 166Ho, 170Tm, 177Lu, 186Re, 199Au and 111Ag in useful quantities was evaluated for the present...

68Ga-Based radiopharmaceuticals: production and application relationship.

The contribution of 68Ga to the promotion and expansion of clinical research and routine positron emission tomography (PET) for earlier better diagnostics and individualized medicine is considerable. The potential applications of 68Ga-comprising imaging agents include targeted, pre-targeted and non-targeted imaging. This review discusses the key aspects of the production of 68Ga and 68Ga-based ...

Centralized HMES with Environment Adaptation for Production of Radiopharmaceuticals